Thought Leader Select

Thought Leader Select Names Castle to Lead Marketing, Client Relations

FOR IMMEDIATE RELEASE MARCH 30, 2010 (CHAPEL HILL, NC)—Thought Leader Select, a North Carolina firm dedicated to better engagement and more sophisticated deployment of key opinion leaders for the pharmaceutical and biotechnology industries, announces the hiring of Brian Castle as director of global marketing and client relations. Mr. Castle, a native of Jackson, MS, spent …

Thought Leader Select Names Castle to Lead Marketing, Client Relations Read More »

The Trifecta of Mutually-Beneficial Relationships: KOLs, Pharma, and Patients—Part Five

Over the past several weeks, we’ve talked about how collaborations among key opinion leaders, clinical investigators and pharmaceutical and biotechnology companies benefit the companies, the KOLs or clinical investigators, and patients. The foundation of these mutually-beneficial collaborations is the objective, methodical approach to understanding KOLs’ and clinical investigators’ skills and experiences. Many methods promise to …

The Trifecta of Mutually-Beneficial Relationships: KOLs, Pharma, and Patients—Part Five Read More »

Thought Leader Select Names Napier to Lead Research Teams

Today’s Press Release from the offices of Thought Leader Select: (CHAPEL HILL, NC)—Thought Leader Select, a North Carolina company dedicated to better engagement and more sophisticated deployment of key opinion leaders (KOLs) for the pharmaceutical and biotechnology industries, announces the hiring of Rhonda Napier as research manager. Ms. Napier, a native of Waterford, PA, brings …

Thought Leader Select Names Napier to Lead Research Teams Read More »

PharmExec's 2010 Forecast Reflected in Thought Leader Select's Current Projects

While 2010 continues to be a challenging year for the pharmaceutical industry as a whole, certain targeted areas of development continue to gain attention from the industry. In PharmExec’s 2010 forecast,Alexandra Kibble predicted continued focus on the following therapeutic areas:  cardiovascular, oncology, and anti-infectives.  Kibble also predicted a rise in pipeline development of treatments for …

PharmExec's 2010 Forecast Reflected in Thought Leader Select's Current Projects Read More »

Thought Leader Select begins key research and advisory services for seven global pharmaceutical companies

New press release out today, celebrating the tremendous efforts of our business development and research teams. FOR IMMEDIATE RELEASE March 9, 2009 (CHAPEL HILL, NC)  Thought Leader Select, a company dedicated to delivering solutions for better engagement and more sophisticated deployment of key opinion leaders (KOLs) for the pharmaceutical and biotechnology industries, announces on-going research …

Thought Leader Select begins key research and advisory services for seven global pharmaceutical companies Read More »

CME Demanding Greater Compliance through Faculty Selection Criteria Consistency

With heightened scrutiny on the objectivity of Continuing Medical Education meetings in recent years, pharmaceutical companies have placed more emphasis on understanding skills and experiences of physician Thought Leaders who may serve as CME faculty. In addition to publishing grant databases which outline monies paid to speakers, CME faculty and other advisors, leading companies are …

CME Demanding Greater Compliance through Faculty Selection Criteria Consistency Read More »

Industry Contraction Spurs New Partnership Opportunities

According to a February 2010 article in Outsourcing-Pharma.com, pharmaceutical companies will continue to outsource more of their business to single-service providers. To capture more business, CROs will merge or focus on niche opportunities. Thought Leader Select, a research firm providing sophisticated KOL deployment strategies to the pharma and biotech industries, has developed a unique opportunity …

Industry Contraction Spurs New Partnership Opportunities Read More »

Thought Leader Select Part of a New Wave of Pharma Partners

An interesting article popped up this week in PharmaLive’s Product Marketing Weekly.  Highlighting a new wave of external partners defining Pharma 3.0, the article focused on the effects of downsizing in the industry, and how pharmaceutical companies, now more than ever, are turning to external partners for non-core business functions. At Thought Leader Select, we …

Thought Leader Select Part of a New Wave of Pharma Partners Read More »

Welcome to Our Blog!

Welcome to the Thought Leader Select Blog.  As we seek new ways to connect with our client companies and provide a more valuable experience with Thought Leader Select, our blog will serve as a venue for providing information about our products, services and the industries we serve, pharma and biotech.